Jim Simons’s Metacrine, Inc. Common Stock MTCR Stock Holding History

Jim Simons’s Portfolio MTCR Stock Details MTCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-574,636	Closed	-$257K	–	4558
2022 Q4	$257K	Sell	574,636 -4,900	-0.8%	-$2.03K	﹤0.01%	3305
2022 Q3	$281K	Sell	579,536 -9,304	-2%	-$4.58K	﹤0.01%	3243
2022 Q2	$294K	Buy	588,840 +165,740	+39%	+$80.3K	﹤0.01%	3466
2022 Q1	$258K	Buy	423,100 +193,800	+85%	+$102K	﹤0.01%	3535
2021 Q4	$155K	Sell	229,300 -53,800	-19%	-$95.9K	﹤0.01%	3596
2021 Q3	$971K	Buy	283,100 +203,200	+254%	+$634K	﹤0.01%	2569
2021 Q2	$304K	Buy	+79,900	New	+$330K	﹤0.01%	3143

Other funds holding MTCR

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Jim Simons's MTCR Position: Q1 2023 in Review

Jim Simons sold out of Metacrine, Inc. Common Stock (MTCR) in Q1 2023, closing a stake of 574,636 shares — an estimated $257K sold.

Jim Simons first reported a position in MTCR in Q2 2021 and held it in 7 quarters. The position peaked at $971K in Q3 2021. 5 funds tracked by Wall St. Rank hold MTCR as of Q1 2023.

Jim Simons reported no remaining Metacrine, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Jim Simons sold 574,636 Metacrine, Inc. Common Stock shares in Q1 2023, an estimated $257K.
Jim Simons first reported a position in Metacrine, Inc. Common Stock in Q2 2021 and held it in 7 quarters.
Jim Simons's Metacrine, Inc. Common Stock position peaked at $971K in Q3 2021.
5 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q1 2023.

Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.